The National Conference on Advances in Pharmaceutical and Biological Sciences (NCAPBS-2026) will be held on 27–28 February 2026 at the School of Pharmaceutical and Biological Sciences, HBTU, Kanpur. The conference aims to provide a platform for researchers, academicians, professionals, and students to share recent developments and innovative research in pharmaceutical and biological sciences. The conference book of abstracts & proceedings will be published by AIJR Publisher.
Important Links
Conference Organizer: School of Pharmaceutical & Biological Sciences, HBTU, Kanpur
Conference WebLink: Click here
Conference Date: 27-28 February 2026
Conference Venue: HBTU, Kanpur
About NCAPBS-2026
This NCAPBS 2026 conference brings together researchers, industry leaders, healthcare professionals, technologists, and regulators to explore the expanding role of artificial intelligence and machine learning in pharmaceutical and biological sciences. It will present advanced research, real world applications, and successful innovations from academia and industry while fostering collaboration among pharmaceutical companies, biotech startups, AI developers, and academic institutions. The program will also examine the ethical, legal, and regulatory responsibilities that guide the safe and effective use of AI in healthcare and life sciences. Scientific sessions will cover biological sciences with AI, including genomics and proteomics, disease modeling, systems biology, computational biology and biomarker discovery, vaccine design, microbiome research, food biotechnology, nanotechnology, and environmental remediation. In pharmaceutical sciences, discussions will address drug discovery and design, predictive pharmacokinetics and pharmacodynamics, drug repurposing, smart drug delivery systems, quality assurance in manufacturing, and high throughput screening. Interdisciplinary themes will include personalized and precision medicine, digital therapeutics and clinical trials, biomedical imaging and signal analysis, ethical and regulatory considerations, entrepreneurship in bio pharma, 3D bioprinting, healthcare devices and diagnostics, and renewable energy with environmental sustainability.
